7Kambia N K,Dine T,Odou P,et al.Pharmacokinetics and dialysa-bility of naltrexone in patients undergoing hemodialysis[J].Eur J Drug Metab Pharmacokinet,2004,29(4):225-230.
8Johnson B A,Ait-Daoud N,Aubin H J,et al.A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence[J].Alcohol Clin Exp Res,2004,28(9):1356-1361.
9Shen Z X.Brain cholinesterases:III.future perspectives of AD research and clinical practice[J].Med Hypotheses,2004,63(2):298-307.
10Hall E D,Springer J E.Neuroprotection and acute spinal cord injury:a reappraisal[J].Neurorx,2004,1(1):80-100.
